瑞信:上調綠城管理(9979.HK)盈利預測 升目標價至6.82港元
瑞信發表研究報吿,將綠城管理(9979.HK)目標價由4.75港元調高至6.82港元,維持跑贏大市評級。
集團日前發盈喜,預期上半年淨利潤按年增不少於70%。瑞信認為,在充滿挑戰的經營環境下,對優質項目管理服務的需求不斷上升,而集團有良好往績,較有優勢。集團有不少政府或國有企業項目,令其不容易受物業市場不確定性的影響。
該行預計集團今年新訂單按年增20%,達到70億元人民幣,其中33%在首季獲得;而擴張快過預期,進一步提高收入增長能見度。基於較高的毛利假設,以及料其2020至2023財年的3年複合年均增長率為26%,該行上調對其2021至2023財年盈利預測5至12%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.